Kentucky Patent of the Month – April 2025
Hera BioLabs has introduced a groundbreaking genetically modified rat model designed to accelerate cancer and immunology research. The innovation, protected under U.S. Patent No. 12,274,247, titled “Genetically modified rat models for severe combined immunodeficiency (SCID),” offers a robust platform for preclinical drug development.
A Leap Forward in Preclinical Models
Traditional mouse models have limitations in size and physiological relevance, often hindering translational research. Hera’s SCID rat model addresses these challenges by providing a larger, more human-like system. This model lacks functional immune cells, allowing for the engraftment of human tissues and tumors without rejection.
The SCID rat’s enhanced compatibility with human cells enables more accurate studies of tumor growth and immune responses. Researchers can now observe disease progression and treatment effects in a setting that closely mirrors human biology.
Real-World Impact on Drug Development
By facilitating more predictive preclinical studies, Hera’s SCID rat model aims to reduce the high attrition rates in clinical trials. Pharmaceutical companies can better assess a drug’s efficacy and safety before proceeding to human testing. This advancement not only streamlines the R&D process but also has the potential to bring effective therapies to patients faster.
The introduction of this model marks a significant step in bridging the gap between laboratory research and clinical application, offering a valuable tool for scientists and developers in the fight against cancer and immune-related diseases.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
